KPV
Research compoundaka Lysine-Proline-Valine
Tiny anti-inflammatory tripeptide off the back of alpha-MSH. Run mostly for gut issues.
Mechanism
The business end of alpha-MSH, just the last three amino acids. Preclinical work points to real anti-inflammatory action, especially in the gut. People run it for exactly that, but it's still early.
Regulatory & Safety Status
Not approved for human use. Research chemical, and the evidence is mostly preclinical.
Research
Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPARγ pathway in HepG2 cells
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review
Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers
Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease
Latest KPV research